3 Reasons I'm Still Bullish On Teladoc
When Teladoc Health (NYSE: TDOC) fell to below $24 a share in October, I couldn't resist the opportunity to average down and buy more shares of the business. Despite all the bearishness surrounding the stock given its slowing growth and the massive impairment charges it has been incurring in recent quarters, this still looks like an investment with tremendous long-term potential.
Teladoc is a top name in telehealth, and the company's recent earnings numbers confirmed that the business remains on that track. Here are three of the main reasons I believe the healthcare stock can turn things around.
One of the reasons I'm optimistic that Teladoc has a path to profitability is that it is able to maintain strong gross margins (what's left after deducting all the direct costs of production). Over the past few years, the company has averaged an impressive gross margin of 66%.
Source Fool.com
